Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed CFO
Quarterly results
Acq. announced
Director departure
CC transcript
MGI PHARMA INC (MOGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/12/2009 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
04/07/2008 SC 13G/A BARCLAYS GLOBAL INVESTORS NA reports a 0% stake in MGI PHARMA INC
02/14/2008 SC 13G PAULSON & CO INC reports a 8.4% stake in MGI PHARMA, INC.
02/14/2008 SC 13G/A SAC CAPITAL ADVISORS LLC reports a 0% stake in MGI PHARMA, INC.
02/14/2008 SC 13G/A D. E. Shaw Composite Portfolios, L.L.C. reports a 1.7% stake in MGI PHARMA, Inc.
02/11/2008 SC 13G/A ADAGE CAPITAL PARTNERS GP LLC reports a 4.3% stake in MGI PHARMA, INC.
02/05/2008 SC 13G BARCLAYS GLOBAL INVESTORS NA reports a 5.9% stake in MGI PHARMA INC
01/28/2008 8-K Quarterly results
01/23/2008 8-K Changes in Control of Registrant, Financial Statements and Exhibits
01/10/2008 SC 13G/A WELLINGTON MANAGEMENT CO LLP reports a 4.6% stake in MGI Pharma, Inc.
01/10/2008 SC 13G/A FMR CORP reports a 2.3% stake in MGI Pharma Inc
01/10/2008 SC 13G/A WESTFIELD CAPITAL MANAGEMENT CO LLC reports a 0% stake in MGI Pharma Inc.
12/27/2007 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "Amendment No. 2 to Rights Agreement, effective as of December 20, 2007, between MGI PHARMA, INC. and Wells Fargo Bank, N.A",
"NOTICE OF CONVERSION RIGHT FOR SENIOR SUBORDINATED CONVERTIBLE NOTES DUE 2024"
12/11/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Eisai Co., Ltd., Jaguar Acquisition Corp. and MGI PHARMA, INC",
"EISAI TO ACQUIRE MGI PHARMA FOR $41 PER SHARE IN AN ALL CASH TRANSACTION"
12/10/2007 SC 13G SAC CAPITAL ADVISORS LLC reports a 5.8% stake in MGI PHARMA, INC.
10/26/2007 10-Q Quarterly Report for the period ended September 30, 2007
10/17/2007 8-K Quarterly results
Docs: "MGI PHARMA Reports Third Quarter 2007 Financial Results"
10/17/2007 TRN MGI Pharma Q3 2007 Earnings Call Transcript
10/12/2007 8-K/A Cost Associated with Exit or Disposal Activities
10/10/2007 SC 13G/A FMR CORP reports a 10.1% stake in MGI PHARMA INC
09/27/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "MGI PHARMA ANNOUNCES SUBMISSION OF AQUAVAN"
08/30/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger dated August 28, 2007, including the form of Stockholder Support and Option Agreement as Schedule A thereto (The Company has omitted certain schedules in accordance with Regulation S-K 6501(b)(2). The Company will submit the omitted schedules to the Commission upon request.)"
07/27/2007 10-Q Quarterly Report for the period ended June 30, 2007
07/18/2007 8-K Quarterly results
Docs: "MGI PHARMA Reports Second Quarter 2007 Financial Results"
06/29/2007 11-K Form 11-K -- Annual report of employee stock purchase, savings and similar plans
05/10/2007 SC 13G/A D. E. Shaw Meniscus Portfolios, L.L.C. reports a 5.2% stake in MGI PHARMA, Inc.
04/27/2007 10-Q Quarterly Report for the period ended March 31, 2007
04/18/2007 8-K Quarterly results
Docs: "MGI PHARMA Reports First Quarter 2007 Financial Results"
03/29/2007 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/01/2007 10-K Annual Report for the period ended December 31, 2006
03/01/2007 10-Q/A Quarterly Report for the period ended September 30, 2006 [amend]
03/01/2007 10-Q/A Quarterly Report for the period ended June 30, 2006 [amend]
03/01/2007 8-K Results of Operations and Financial Condition, Non-Reliance on Previously Issued Financial Statements or a Related Audit Repo...
Docs: "MGI PHARMA AMENDS QUARTERLY FILINGS FOR SECOND AND THIRD QUARTERS OF 2006"
02/14/2007 SC 13G/A D. E. Shaw Meniscus Portfolios, L.L.C. reports a 6.4% stake in MGI PHARMA, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy